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Azole sensitivity in Leptosphaeria 
pathogens of oilseed rape: the role 
of lanosterol 14α-demethylase
Thomas R. Sewell1,2, Nichola J. Hawkins3, Henrik U. Stotz1, YongJu Huang1, Steven L. Kelly4, 
Diane E. Kelly4, Bart Fraaije3 & Bruce D. L. Fitt1
Lanosterol 14-α demethylase is a key enzyme intermediating the biosynthesis of ergosterol in fungi, 
and the target of azole fungicides. Studies have suggested that Leptosphaeria maculans and L. 
biglobosa, the causal agents of phoma stem canker on oilseed rape, differ in their sensitivity to some 
azoles, which could be driving pathogen frequency change in crops. Here we used CYP51 protein 
modelling and heterologous expression to determine whether there are interspecific differences at the 
target-site level. Moreover, we provide an example of intrinsic sensitivity differences exhibited by both 
Leptosphaeria spp. in vitro and in planta. Comparison of homologous protein models identified highly 
conserved residues, particularly at the azole binding site, and heterologous expression of LmCYP51B 
and LbCYP51B, with fungicide sensitivity testing of the transformants, suggests that both proteins are 
similarly sensitive to azole fungicides flusilazole, prothioconazole-desthio and tebuconazole. Fungicide 
sensitivity testing on isolates shows that they sometimes have a minor difference in sensitivity in vitro 
and in planta. These results suggest that azole fungicides remain a useful component of integrated 
phoma stem canker control in the UK due to their effectiveness on both Leptosphaeria spp. Other 
factors, such as varietal resistance or climate, may be driving observed frequency changes between 
species.
Antifungal demethylation inhibitors (DMIs), e.g. triazoles and imidazoles (azoles), target lanosterol 
14α-demethylase (CYP51, erg11), a member of the cytochrome P450 superfamily and key regulatory enzyme in 
the ergosterol biosynthetic pathway1,2. Ergosterol is an essential structural component of the fungal plasma mem-
brane and is required to maintain membrane integrity, fluidity and permeability. Inhibition of CYP51 blocks the 
synthesis of ergosterol, which subsequently increases cytotoxic sterol precursors. The lack of membrane-bound 
ergosterol and the accumulation of toxic metabolites in the cytosol have a combined fungistatic effect on the cell, 
decreasing membrane integrity and permeability3.
Azoles are used to control fungal pathogens in both clinical and agricultural situations. In clinical settings, 
voriconazole, itraconazole and posaconazole are commonly used to treat the opportunistic human pathogen 
Aspergillus fumigatus, which can cause invasive pulmonary infections amongst immunocompromised patients4, 
along with other invasive pathogens, e.g. Candida spp5. In agriculture, a wide range of azole fungicides have been 
used to control fungal plant pathogens since their inception in the 1970s6. Since 2005, azole fungicides have 
maintained approximately 20% share of the global fungicide market, which in total (including seed treatments) 
was worth $13.3 billion in 20116–8.
Agricultural azole fungicides are used as a component of fungicide programmes (often in mixtures) to control 
fungal diseases, including phoma stem canker of winter oilseed rape (Brassica napus) caused by coexisting fungal 
plant pathogens Leptosphaeria maculans and L. biglobosa9. Globally, phoma stem canker causes approximately 
£700 million worth of yield losses, making it a considerable threat to sustainable oilseed rape production and 
food security10.
Recent studies have suggested that the two Leptosphaeria spp. differ in their sensitivity to azoles, both in 
vitro11 and in planta12, with L. biglobosa exhibiting a less sensitive phenotype in the presence of flusilazole and 
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tebuconazole. Differences in sensitivity between coexisting plant pathogens can affect population structure13 and 
it has been suggested that lower azole sensitivity could explain the recent increase in L. biglobosa incidence in 
some UK locations14.
Increased exposure to azole fungicides has led to the evolution of resistance in some plant pathogen popu-
lations. Currently, four mechanisms of resistance to DMIs have been identified in agricultural crop pathogens; 
these are (1) target site polymorphisms (2) CYP51 overexpression (3) presence of CYP51 paralogs (CYP51A, 
CYP51B, CYP51C) and (4) increased expression of efflux pump genes6,15,16. Missense mutations in the cod-
ing sequence of erg11, the gene that encodes CYP51, and subsequent alterations in the secondary structure of 
CYP51, correlate with an insensitivity to DMI fungicides and are currently the most common mechanism of 
azole-resistance6,15,17–19. Using predictive homology modelling, polymorphisms in the CYP51 coding sequence 
have shown to directly interfere with binding and/or increase the size of the azole binding pocket, thus decreasing 
the affinity of the bound fungicide and reducing its effectiveness as an anti-fungal20.
Using predictive homology modelling supported by heterologous expression in a Saccharomyces cerevisiae 
mutant, we have investigated if CYP51 structural differences play a role in fungicide-sensitivity differences previ-
ously reported between Leptosphaeria maculans and L. biglobosa populations. Moreover, using a subset of isolates 
from south east UK, we sought to confirm established reports of fungicide sensitivity in L. maculans and L. biglo-
bosa and provide a mechanistic example of this both in vitro and in planta.
Results
Characterisation and sequencing of Lmerg11/CYP51B and Lberg11/CYP51B. All 12 L. maculans 
isolate sequence assemblies (GenBank accession numbers KY500978 – KY500989) encompassed Lmerg11, which 
was 1635 bp in length and consisted of two exons and one 54 bp intron; nucleotide sequence similarity between 
all isolates was 100%. LmCYP51B was identical in all 12 isolates but differed by 1 amino acid (K337N) when 
compared with the published LmCYP51B sequence (AAN28927.1) from an Australian isolate (M1). Lberg11 
was conserved within all L. biglobosa sequence assemblies (GenBank accession numbers KY500970–KY500977), 
was 1642 bp in length and consisted of two exons and one 58 bp intron. Of the eight isolates sequenced, six 
had an identical erg11 gene, while two isolates (F2 dm 11-5 and H Dr 12 12) contained a synonymous single 
nucleotide polymorphism (SNP), namely C1467T; therefore all 8 protein sequences were 100% similar. Neither 
Leptosphaeria spp. contained amino acid alterations previously recognised as conferring reduced azole sensitivity 
in other plant pathogenic fungi6.
A pair-wise alignment between LmCYP51B and LbCYP51B identified 24 amino acid alterations, one amino 
acid deletion and a pair-wise percentage identity of 97.5% (Score matrix = BLOSUM80, threshold = 1) (SF 2). Of 
the 24 alterations, 12 were considered a change to amino acids with similar physical-chemical properties and 12 
considered a change to amino acids with dissimilar physical-chemical properties (Score matrix = BLOSUM80, 
threshold = 1).
Phylogenetic analysis by maximum likelihood clearly shows that CYP51B from L. maculans and L. biglobosa 
are sister lineages within the Pezizomycotina CYP51B clade (Fig. 1). CYP51B is a CYP51 paralog found in all 
filamentous ascomycetes. An additional paralog and functioning sterol 14-α demethylase, CYP51A, for which 
high levels of expression are associated with reduced azole sensitivity in some filamentous ascomycetes16, was 
Figure 1. Maximum Likelihood phylogenetic tree of fungal CYP51 sequences including all three CYP51 
paralogs: CYP51A (green) CYP51B (blue) and CYP51C (yellow). Closest match to CYP51A and CYP51C in 
Leptosphaeria spp. genomes are also displayed, as are the Leptosphaeria spp. CYP51B paralogs identified in 
this study (red). The evolutionary history was inferred by using the maximum likelihood method based on the 
general time reversible model41. Branch lengths scaled by number of substitutions per site. Node labels indicate 
percentage bootstrap support (1000 replicates).
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not found in either Leptosphaeria species. Moreover, CYP51C, a non-functionalised paralog found in Fusarium 
spp.21, was not identified in either of the Leptosphaeria spp. genomes (Fig. 1).
Predictive homology modelling. For both species, all five CYP51B models that were predicted by 
Modeller had a very high structural fold confidence (P < 0.001) and a global model quality score of 0.89 (0 to 1 
scale). The best models for each species, according to ModFOLD4, were selected for further analysis. The pre-
dicted structures of LmCYP51B and LbCYP51B were very similar (TM-score = 0.90). The root-mean-square 
deviation (RMSD) of the common residues was 2.76 Å on a 526 amino acid alignment length (Fig. 2). The glob-
ular active sites of the proteins appear to have the highest structural conservation. Noteworthy differences in the 
predicted structures were distinguishable only in the trans-membrane tail, although some amino acid substitu-
tions did slightly alter the predicted fold of the globular structure. The heme cofactor and subsequently bound 
prothioconazole-desthio ligand were shown to be located inside the binding pocket of the proteins. The sur-
rounding amino acids, which form this pocket, were all highly conserved (Fig. 3).
Detailed two-dimensional schematics of protein-ligand interactions identified further similarities between the 
predicted structures of LmCYP51B (SF 3a) and LbCYP51B (SF 3b). A water-mediated hydrogen bond network 
was maintained in both structures, specifically facilitated by the presence of Tyr136, a water molecule and the 
relative location of the heme cofactor. Furthermore, five other residues, Tyr122, Ala306 (Ala307 in LbCYP51B), 
Ile372 (Ile373 in LbCYP51B), Ser374 (Ser375 in LbCYP51B) and Phe508 (Phe509 in LbCYP51B), which were 
interacting with the bound ligand (prothioconazole-desthio), were correspondingly located in the binding pocket 
(Fig. 3). The predicted structure of LbCYP51B had two extra residues, Ser311 and Leu508, both located suffi-
ciently close to interact with the ligand.
Heterologous expression of LmCYP51B and LbCYP51B in Saccharomyces cerevisiae. The 
vector-only transformed strain YUG37::pYES2/CT, which lacked a complementary CYP51B protein, was 
unable to grow on the doxycycline amended SD GAL + RAF medium due to the repression of native CYP51B 
expression in S. cerevisiae. Complementation of native CYP51B was achieved in YUG37::LmCYP51B and 
YUG37::LbCYP51B S. cerevisiae transformants, which both showed robust growth across five 5-fold dilutions on 
SD GAL + RAF medium amended with doxycycline; demonstrating that expression of the predicted wild-type 
CYP51B protein from L. maculans or L. biglobosa can support ergosterol synthesis in S. cerevisiae (Fig. 4).
All YUG37 transformants expressing LmCYP51B or LbCYP51B were very sensitive to tebuconazole, flusila-
zole and prothioconazole-desthio (Table 1). There was a marginal, 1.35-fold (1 df, P < 0.05) difference between 
Figure 2. Structural pair-wise alignment (Match >Align; Chimera) on the predicted homology models of 
LmCYP51B and LbCYP51B (a). Difference in colour represents distance (Å) between aligned residues (RMSD), 
with red representing residues close in structural locality and blue representing residues that are further apart. 
Zoomed image (b) is a cross-section of the binding pocket of aligned proteins. Heme cofactor is coloured in 
white and bound azole ligand in black. Images were generated using Chimera.
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the EC50 values of YUG37::LmCYP51B and YUG37::LbCYP51B transformants for tebuconazole, and no signifi-
cant difference in sensitivity to flusilazole or prothioconazole-desthio.
Fungicide sensitivity in vitro. Both species were very sensitive to prothioconazole-desthio, flusilazole and 
tebuconazole (Figs 5 and ST 1). Comparison between L. maculans (n = 23) and L. biglobosa (n = 21) isolates iden-
tified a significant difference in sensitivity to flusilazole (Fig. 5a) (W = 373, P < 0.01) and prothioconazole-desthio 
(Fig. 5b) (W = 39, P < 0.001). L. maculans isolates were 2.07 times less sensitive than L. biglobosa isolates to 
Figure 3. Azole binding sites in the Leptosphaeria maculans CYP51B (a) and L. biglobosa CYP51B (b) proteins 
inferred by homology. Superimposed prothioconazole-desthio (5L9) is highlighted in orange with residues 
<5 Å from ligand (5L9) labelled. The heme cofactor is highlighted in pink and the metal-ligand bond in purple. 
Hydrogen bonds are highlighted in blue and water molecules (HOH) in red. Images were generated in Chimera.
Figure 4. Complementation of Saccharomyces cerevisiae strain YUG37::erg11 with Leptosphaeria maculans 
CYP51B and Leptosphaeria biglobosa CYP51B. Yeast transformants grown for 16 hours in SD + GAL + RAF 
media were inoculated onto SD + GAL + RAF agar without (DOX−) or with (DOX+) doxycycline, which 
represses the native S. cerevisiae CYP51B. The YUG37::pYES2/CT vector-only strain was used as a control. 
Lettering (a,b) refers to biological replicates.
Transformant Tebuconazole
Fold 
difference Flusilazole
Fold 
difference
Prothioconazole-
desthio
Fold 
difference
YUG37::LmCYP51B 0.0084 (0.0017) 0.036 (0.014) 0.0007 (0.0006)
YUG37::LbCYP51B 0.0062 (0.0005) 1.35* 0.032 (0.0056) 1.13 0.0004 (0.0002) 1.75
Table 1. Fungicide sensitivity (EC50 µg ml−1) of YUG37::LmCYP51B and YUG37::LbCYP51B Saccharomyces 
cerevisiae transformants. Standard deviations (±) were calculated from two biological replicates.
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prothioconazole desthio, whereas L. biglobosa was 1.31 times less sensitive to flusilazole than L. maculans. There 
was no significant difference in sensitivity to tebuconazole (Fig. 5c).
Prothioconazole sensitivity in planta. At 14 days post inoculation (DPI), treatment with pro-
thioconazole showed a significant effect on L. maculans or L. biglobosa lesion diameter (Kruskal-Wallis 
chi-squared = 124.4, 2 df, P < 0.05) (Fig. 6), with lesion diameter decreasing as concentration increased. A con-
centration of 20 µg ml−1 prothioconazole reduced both L. maculans and L. biglobosa lesion size by three-fold 
compared to the untreated control. Moreover, L. biglobosa and L. maculans lesions were not statistically different 
in their size on prothioconazole-treated leaves.
DNA quantity for each treatment was determined using qPCR to measure the effect prothioconazole treat-
ment has on pathogen growth (Fig. 7) in planta. Both 2 and 20 µg ml−1 of prothioconazole significantly decreased 
the amount of L. maculans DNA in leaf tissue when compared to the untreated control (2 df, P < 0.05); however, 
there was no significant difference in DNA quantity between 2 and 20 µg ml−1. There was no significant difference 
in the amount of L. biglobosa DNA within leaf tissues treated across all three concentrations (0, 2, 20 µg ml−1).
Discussion
Heterologous expression of lanosterol 14α-demethylase (CYP51B) from Leptosphaeria maculans (LmCYP51B) 
and L. biglobosa (LbCYP51B), together with subsequent fungicide sensitivity assays on the yeast transformants, 
show that LmCYP51B and LbCYP51B interact similarly with azole fungicides tebuconazole, flusilazole and 
Figure 5. Box plot depicting sensitivities of Leptosphaeria maculans (yellow) isolates (n = 23) and L. biglobosa 
(blue) isolates (n = 21) to flusilazole (a), prothioconazole-desthio (b) and tebuconazole (c). Thick line denotes 
median value, box edges signify lower and upper quartiles and error bars represent minimum and maximum 
values.
www.nature.com/scientificreports/
6SCIEnTIFIC REpORTS | 7: 15849  | DOI:10.1038/s41598-017-15545-9
prothioconazole-desthio. These observations support the homology modelling predictions that LmCYP51B and 
LbCYP51B share a high level of structural similarity, specifically at the azole-binding site.
Sequence analysis indicated that both LmCYP51B and LbCYP51B contained no previously identified CYP51B 
mutations that confer azole resistance or azole insensitivity in other plant and human pathogenic fungi8,22–24. 
Therefore, evolution of resistance to azole fungicides, which has been strongly linked to the gradual develop-
ment of missense mutations in the CYP51B amino acid sequence17,18,20,25,26, has not yet occurred in either the L. 
maculans or the L. biglobosa populations sampled. Nonetheless, further analysis was warranted due to multiple 
amino acid substitutions between LmCYP51B and LbCYP51B, plus two extra residues in LbCYP51, that could 
potentially affect the tertiary structure of the proteins and thus the azole binding potential.
Changes to the structure of CYP51B have previously been proposed to alter the affinity of azoles, such as tebu-
conazole or triadimenol; this was determined through predictive homology modelling of wild type (MgCYP51B) 
and mutant CYP51B proteins found in insensitive Mycosphaerella graminicola populations20. More recently, anal-
ysis of a high resolution S. cerevisiae CYP51B structure (PDB:4WMZ), co-crystallised with medical azole flucona-
zole, identified two water molecules within the active site of the proteins that form a network of hydrogen bonds 
adhering the azole to the protein27. The presence of Y136F/H substitution (ScCYP51B) breaks one part of this 
water-mediated hydrogen bond network due to the loss of the hydroxyl group incurred by the tyrosine to phe-
nylalanine or histidine substitution. This reduces the azole binding capacity of the proteins, confirmed through 
spectral characterisation of fluconazole binding with the wildtype ScCYP51B protein or Y140F/H mutants28.
Here the predicted structures of LmCYP51B and LbCYP51B have been compared through the structural 
alignment of homology models. Prothioconazole-desthio, the more active in planta metabolite of agricultural 
azole prothioconazole29, was superimposed using its confirmation in co-crystallised ScCYP51B structure 
PDB:5EAD. Analysis of the alignment (Fig. 3) noticeably illustrates that structural conservation is maintained 
throughout the globular pocket. Only in the transmembrane tail is there any noticeable distance between the 
aligned residues. Locality of residues: Y136, K147 and *G461/G462 (*LmCYP51B/LbCYP51B, respectively), 
which correspond to substitutions Y132F, K143R and G464S in resistant Candida albicans isolates (Y140F, K151R 
and G464S in ScCYP51B)24, are all conserved in L. maculans and L. biglobosa. In addition to this, Y122 (Y126 in 
ScCYP51B) and *S374/S375 (S383 in ScCYP51B), which form a water-mediated hydrogen bond network with 
another water molecule when fluconazole is bound, are also structurally conserved.
Figure 6. Efficacy of prothioconazole on the leaf lesions of Leptosphaeria maculans (yellow) and L. biglobosa 
(blue). Oilseed rape cotyledons (cv. Catana) were inoculated with either L. maculans or L. biglobosa conidial 
suspension (×106). At 6 days post inoculation (DPI), cotyledons were sprayed with prothioconazole at 
0 µg ml−1, 2 µg ml−1 or 20 µg ml−1 concentration (a). Lesion diameter (mm) was recorded and average lesion 
diameter calculated as percentage compared to control (b). Error bars represent standard errors of the mean.
www.nature.com/scientificreports/
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Consequentially, it can be postulated that the wild type LmCYP51B and LbCYP51B proteins would inter-
act with azole fungicides similarly due to the likeness of key structural locations and the preservation of a 
water-mediated hydrogen bond network in the predicted homology models. This hypothesis was tested using 
heterologous yeast expression and subsequent fungicide sensitivity assays, to investigate the efficacy of various 
azole fungicides on LmCYP51B and LbCYP51B within an isogenic background; previous studies have used this 
method to investigate the effects of CYP51B mutations on fungicide efficacy, showing a causal link between key 
mutations and resistant phenotypes16,17,26. Both LmCYP51B and LbCYP51B yeast transformants responded simi-
larly to azole treatment, suggesting that the affinity of various azole fungicides to both LmCYP51B and LbCYP51B 
is similar, with the only significant difference between the two transformants a 1.35-fold change in tebuconazole 
EC50. This represents a minor and possibly non-effective difference in the field, especially when compared to 
MgCYP51B harbouring mutations L50S and Y461H, which conferred a resistance factor (fold-change against 
wild-type) of 63.2 to tebuconazole and 192 to triadimenol, when expressed in yeast26.
Furthermore, this small difference in sensitivity of the heterologously-expressed proteins was not observed 
at the organism level, where both L. maculans and L. biglobosa isolates had a similar response to tebucona-
zole in vitro. Interestingly, the two species did differ in their sensitivity to flusilazole (2.07 fold change) and 
prothioconazole-desthio (1.31 fold change), both of which did not exhibit a differing effect on LmCYP51B and 
LbCYP51B when heterologously expressed in yeast. It is possible that these minor differences in sensitivity could 
be due to natural variation in the uptake, efflux or metabolism of fungicide compounds, however to determine 
this would require further investigation.
Ultimately, all L. maculans and L. biglobosa isolates sampled were sensitive to tebuconazole, flusilazole and 
prothioconazole-desthio. The distribution of EC50 values for each fungicide were small, suggesting that no iso-
late in our collection had developed increased resistance to fungicides. However, our data set provides only an 
example of intrinsic sensitivity of the two species from a mechanistic perspective and does not rule out sensitivity 
variation in the wider population. Nonetheless, on-going field studies conducted on a yearly basis in the UK by 
the Agricultural and Horticultural Board, have yet to identify a shift in sensitivity by either Leptosphaeria spp, 
with fungicides remaining effective for the control of phoma stem canker30.
Figure 7. Quantification of DNA from prothioconazole-treated oilseed rape cotyledons inoculated with 
either L. maculans (a) or L. biglobosa (b). Oilseed rape cotyledons (cv. Catana) were inoculated with either L. 
maculans or L. biglobosa conidial suspension (×106 conidia ml−1). At 6 days post inoculation (DPI), cotyledons 
were sprayed with prothioconazole at either 0 µg ml−1, 2 µg ml−1 or 20 µg ml−1 concentration. Cotyledons were 
sampled at 14 DPI and DNA was extracted (25 ng μl−1). Quantitative PCR was done on duplicate samples and 
run alongside a standard curve for quantification of DNA (pg ul−1). Data were log10-transformed. Asterisks 
denote significance when compared with the control (*P < 0.05, **P < 0.01 ***P < 0.001) and error bars 
represent standard deviation.
www.nature.com/scientificreports/
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These in vitro sensitivity data, together with CYP51B sequence analysis, are in line with previous studies 
that found no evidence of azole resistance among populations of either L. maculans or L. biglobosa11,12. Some 
similarities in sensitivity are observed in planta, with prothioconazole treatment having comparable effects on 
L. maculans and L. biglobosa lesion size when colonising oilseed rape cotyledons. However, only L. maculans 
DNA quantity was significantly affected by 2–20 ng ml−1 prothioconazole, suggesting that L. biglobosa may have 
a minor difference in sensitivity to prothioconazole treatment in planta or maybe less virulent on the tested culti-
var since DNA quantity was much lower when compared to L. maculans. Further work using a wider range of L. 
biglobosa and L. maculans isolates is needed before conclusions on in planta sensitivity differences can be made. 
Overall, in light of just minor sensitivity differences both in planta and in vitro, changes in species frequency due 
to fungicide application, previously reported in other plant pathogens such as Tapesia spp.13, are unlikely to be the 
reason behind recent reports of increased L. biglobosa incidence14. Other factors, such as climatic pressures31,32, 
varietal specificity33,34 or even other anthropological influences such as pollution level35 could explain these fre-
quency alterations and should be prioritised for further investigation.
Fungicides remain an essential component of integrated disease management and improved understanding 
of their efficacy on crop diseases is imperative. Knowledge that L. maculans and L. biglobosa have yet to evolve 
resistance to the azole fungicides tested here, reinforces confidence in the durability of these chemicals for the 
management of phoma stem canker and their suitability as mixing partners for higher risk fungicide groups. This 
knowledge, coupled with evidence suggesting that there is no great difference in azole sensitivity between the two 
species, suggests that currently neither pathogen will be actively selected through the prolonged usage of these 
fungicides. Further investigation into the potential future evolution of fungicide resistance of L. maculans and 
L. biglobosa, through the generation of laboratory mutants, will help towards enhancing the longevity of fungi-
cides for future control of these pathogens. Furthermore, additional analysis into L. maculans and L. biglobosa 
frequency fluctuations, and the importance of L. biglobosa to UK oilseed rape production, is essential, but with a 
focus on environmental and varietal selection pressures.
Methods
Characterisation of erg11 and CYP51B in L. biglobosa. L. biglobosa CYP51B (LbCYP51B) charac-
terisation began with a BLASTp search of GenBank using the published L. maculans CYP51B (LmCYP51B) 
protein sequence (AAN28927.1). A Clustal Omega multiple sequence alignment was generated using six protein 
sequences with similar percentage identity: Pyrenophora tritici-repentis (XP_001939023.1), Alternaria alternata 
(OAG21175.1), Stagonosporopsis caricae (AMM76225.1), Botrytis cinerea (CCD54835.1), Sclerotinia sclerotiorum 
(XP_001594997.1) and Aspergillus nidulans (XP_681552.1)36,37. Using the alignment, a 13 amino acid region 
(DVVYDCPNSKLME) conserved across five of the six aligned species was selected for a custom BLASTp search 
using Geneious R9.1.4 (Biomatters Limited, New Zealand), which was executed against a database of translated 
open reading frames generated from published L. biglobosa genome data provided by INRA-Bioger, France38. The 
corresponding nucleotide sequence was manually identified using an annotations text search; BLASTn search was 
performed to corroborate the putative LbCYP51 nucleotide sequence.
LmCYP51B and LbCYP51B sequencing. Total DNA from 12 L. maculans isolates and eight L. biglobosa 
isolates (ST 1) was extracted using DNAMITE Plant DNA extraction kit (Microzone) according to manufacturer’s 
specifications. PCR amplification was completed using sequencing primers for both species (ST 2) and REDTaq 
DNA polymerase (Sigma). Amplification conditions for both species were 1 cycle at 95 °C for 2 min; 35 cycles at 
95 °C for 40 sec, 53.5 °C for 30 sec and 72 °C for 1 min; followed by a final extension at 72 °C for 5 min. PCR prod-
ucts were purified with a QIAquick PCR Purification kit (Qiagen, USA) according to the manufacturer’s guide-
lines. For sequencing, samples were prepared to a final concentration of 20–30 ng µl−1 and sent to GATC Biotech 
for Sanger sequencing; sequence data were analysed using Geneious R9.1.4 and contigs assembled using Cap339, 
with low quality ends trimmed manually. Constructed contigs were aligned with the published LmCYP51B gene 
sequence (AY142146) as the reference sequence. Sequences were manually trimmed to the start (ATG) and stop 
codon (TAG). The recognised location of a single intron in LmCYP51B was removed manually. The predicted 
location of a single intron in LbCYP51B, inferred from the alignment with L. maculans reference sequence, was 
also removed. Finally, nucleotide sequences were checked using ORF Finder (NCBI 2016) and translated into 
amino acid sequence using Geneious R9.14.
Phylogenetic analysis was conducted using Molecular Evolutionary Genetics Analysis (MEGA7) software40. 
Firstly, CYP51A/B/C orthologs were obtained using a BLASTn search of GenBank with the published LmCYP51B 
nucleotide coding sequence from L. maculans and the CYP51A/C nucleotide coding sequences from Fusarium 
graminearum. Sequences were translated and a Clustal Omega alignment performed on the translated CYP51B 
protein sequences from L. maculans CYP51B, L. biglobosa CYP51B, P. tritici-repentis CYP51B, A. alternata 
CYP51B, Phaeosphaeria nodorum CYP51B (XM_001938988.1), Stagonosporopsis cucurbitacearum CYP51B 
(ANP43771.1), B. cinerea CYP51B, S. sclerotiorum CYP51B, F. graminearum CYP51B (FJ216402.1), A. fumig-
atus CYP51B (XM_744041.1), A. flavus CYP51B (KOC13803.1), A. niger CYP51B (GAQ46773.1), F. gramine-
arum CYP51A (JN41662.1), A. fumigatus CYP51A (JX283445.1), F. graminearum CYP51C (AGG55728.1) and 
Saccharomyces cerevisiae CYP51 (NP_011817.1), with Homo sapiens CYP51 (NP_000777.1) as an outgroup. In 
order to identify potential CYP51 paralogs in both Leptopshaeria spp., a tBLASTn search was performed on the 
two Leptopshaeria spp. genomes using F. graminearum CYP51A/C protein sequences and the S. cerevisae CYP51 
sequence. The closest match that was not CYP51B was included in the alignment and subsequent phylogeny. A 
codon alignment was used for model selection through maximum-likelihood (BIC) and then phylogenetic rela-
tionships were inferred by maximum-likelihood using the general time reversible nucleotide substitution model41 
with 1000 bootstrap replications.
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Comparative homology modelling. Predictive homology protein modelling was processed in Chimera42 
using Modeller v9.1443. Firstly, to identify similar CYP51B sequences that have been structurally solved, a 
BLASTp search of the protein data bank (PDB) database was done individually on LmCYP51B and LbCYP51B 
amino acid sequences.
A Clustal Omega multiple sequence alignment was performed on the three most homologous CYP51B pro-
tein sequences, together with either LmCYP51B or LbCYP51B. For both Leptosphaeria spp., the closest solved 
CYP51B structures were from A. fumigatus, S. cerevisiae and H. sapiens (SF 1a-b). In Chimeria, bound ligands 
within these structures were removed and the heme cofactor, which is an important feature of CYP51B, was man-
ually removed from the S. cerevisiae and H. sapiens structures but conserved from A. fumigatus, as this was the 
protein with the highest sequence identity.
The Advanced options in Modeller v9.14 were used to build the model with hydrogens and the num-
ber of output models was set to five. Selection of the most reliable model was done using ModFOLD444. 
Prothioconazole-desthio, in the PDB: 5EAD binding confirmation was superimposed into the predicted struc-
tures using Matchmaker in Chimera with parameters set to default. Hydrogen bonds were predicted using 
H-bond finder in Chimera with parameters set to default. A structural alignment (TM-align) resulting from 
a residue-to-residue comparison was generated with a 0 to 1 scoring system where 1 indicates a perfect match 
between the two structures45.
Heterologous expression of LmCYP51 and LbCYP5 in Saccharomyces cerevisiae. Total RNA 
was extracted from one L. maculans (Hrox 12-2-1) and one L. biglobosa (F2 dm 11-5) isolate using the RNeasy 
Plant Mini Kit (Qiagen). Mycelium of each species was grown in Sabouraud dextrose broth for 10 days, harvested 
through centrifugation, flash-frozen in liquid nitrogen, freeze-dried for 24 h and then ground into a fine powder. 
The remaining RNA extraction procedure was done according to manufacturer’s instructions. Complementary 
DNA (cDNA) was synthesised from 1 µg of total RNA using the SuperScript® IV First-Strand Synthesis System 
(SSIV) (Invitrogen) according to manufacturer’s guidelines. The complete LmCYP51B and LbCYP51B coding 
sequences were amplified using primer pairs LmCYP51res (forward/reverse) and LbCYP51res (forward/reverse) 
(ST 2). Restriction primers introduced a HindIII restriction site to the 5″ end and a NotI restriction site to the 3″ 
of the amplified CYP51B sequences.
A touchdown-PCR46 was completed using EasyA High Fidelity PCR Cloning Enzyme (Agilent, USA). 
Amplification conditions for LmCYP51 were 1 cycle at 94 °C for 2 min; 7 cycles at 94 °C for 30 sec, 59 to 53 °C each 
for 1 min (1 °C decrease per cycle) and 72 °C for 2 min; 28 cycles at 94 °C for 30 sec, 52 °C for 1 min and 72 °C for 
1 min; followed by a final extension at 72 °C for 7 min. Amplification conditions for LbCYP51 were 1 cycle at 94 °C 
for 2 min; 7 cycles at 94 °C for 30 sec, 58 to 52 °C each for 1 min (1 °C decrease per cycle) and 72 °C for 2 min; 28 
cycles at 94 °C for 30 sec, 56 °C for 1 min and 72 °C for 1 min; followed by a final extension at 72 °C for 7 min. PCR 
products were purified, cloned into the pGEM-T easy vector (Promega, USA) and transformed into high effi-
ciency JM109 competent cells (Promega) using ampicillin selection and blue-white screening, all according to the 
manufacturer’s specification. Colony PCR used primers LmCYP51res (forward/reverse) and LbCYP51res (for-
ward/reverse) to determine successful ligation of LmCYP51B or LbCYP51B. PCR was carried out using REDTaq 
DNA polymerase (Sigma) with a 52 °C or 51 °C annealing temperature, respectively, and 40 seconds extension 
time. Plasmids were extracted using the QIAprep Spin Miniprep Kit (Qiagen).
Restriction digestions of pGEM-T-LmCYP51 and pGEM-T-LbCYP51 constructs were prepared using HindIII 
and NotI high fidelity enzymes (New England Biolabs) according to manufacturer’s double-digestion specification. 
The yeast vector, pYES2/CT (Thermo Fisher, USA) was digested under the same conditions. Digested pYES2/CT, 
LmCYP51 and LbCYP51 were purified by gel electrophoresis (0.7% agarose) using QIAquick gel extraction kit 
according to manufacturer’s specification. Purified samples were then ligated and transformed into high efficiency 
JM109 competent E. coli cells. Colony PCR was used to check which E. coli colonies had the correct insertion. 
Positive transformants underwent plasmid extraction and the purified pDNA was used for transformation of S. 
cerevisiae strain YUG37: erg11 (MATa ura3-52 trp1-63 LEU2::tTA tetO- CYC1::erg11)47 using the S.c EasyComp 
transformation kit (Invitrogen, USA). YUG37:LmCYP51B and YUG37:LbCYP51B transformants were plated out 
onto synthetic dropout minimal medium (SD) containing 4 g l−1 yeast nitrogen base without amino acids (Sigma), 
3.92 g l−1 dropout medium supplement without uracil (Sigma), 2% galactose (GAL) and 2% raffinose (RAF).
YUG37:LmCYP51B, YUG37:LbCYP51B and YUG37:pYES2/CT (negative control) transformants were 
grown in 10 ml liquid SD medium for 24 h at 30 °C with shaking (250 RPM). Cell suspensions were diluted to a 
concentration of 106 cells ml−1 and inoculated onto SD GAL + RAF agar plates with or without 3 µg ml−1 doxycy-
cline (5 µl of five 5-fold dilutions). Plates were incubated at 30 °C and photographed after 5 days.
Fungicide sensitivity of yeast transfomants. Fungicide sensitivity of YUG37:LmCYP51B and 
YUG37:LbCYP51B transformants was tested using flusilazole, tebuconazole and prothioconazole-desthio fun-
gicides (2 independent transformants per protein). A single transformant colony was grown in 10 ml liquid SD 
GAL + RAF for 24 h at 30 °C with shaking. The resultant cell suspensions were diluted to a concentration of 106 
cells ml−1 and 100 µl aliquots were added to a flat-bottomed 96-well microtitre plate. The microtitre plate was sub-
sequently populated with 100 µl of SD GAL + RAF media with doxycycline (6 µg ml−1), which had been amended 
with decreasing concentrations of fungicide (5, 1.7, 0.56, 0.19, 0.062, 0.021, 0.0069, 0.0023, 0.00076, 0.00025, 
8.47 × 10−5, 2.82 × 10−5, 0 µg ml−1). Plates were incubated at 30 °C for 6 days. Fungal growth was measured by 
absorbance using a FLUOstar OPTIMA microplate reader (BMG Labtech, Offenburg, Germany) set to 630 nm 
in endpoint mode. Fungicide sensitivities for each isolate were calculated as 50% effective concentrations (EC50) 
using a dose-response relationship curve generated by the FLUOstar OPTIMA microplate software. Distribution 
of data was determined using a Shapiro-Wilk normality test in R48. Significant differences in the distribution of 
EC50 values between species were determined using a One-Way ANOVA in R.
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Fungicide sensitivity in vitro. Sensitivity assays, modified from those of Pijls et al.49, consisted of 2x sab-
ouraud dextrose media amended with decreasing concentrations of technical grade flusilazole, tebuconazole (20, 
10, 5, 2.5, 1.25, 0.63, 0.31, 0.16, 0.078, 0.039, 0.020, 0 µg ml−1 final concentration) or prothioconazole-desthio (20, 
6.67, 2.22, 0.74, 0.25, 0.082, 0.027, 0.009, 0.003, 0.001, 0.0003, 0 µg ml−1 final concentration). Aliquots (100 µl) 
of the fungicide-amended media were added to the wells of flat-bottomed 96-well microtitre plates (NUNC™, 
Thermo Fisher, USA). Aliqouts (100 µl) of individual conidial suspensions (106 conidia ml−1) of 23 L. maculans 
isolates and 22 L. biglobosa isolates (isolated between 2014 and 2015) were added to each well of a single row (in 
duplicate). Plates were incubated at 20 °C for 4 days and fungal growth measured by absorbance using a FLUOstar 
OPTIMA microplate reader, as previously described. Distribution of data was determined using a Shapiro-Wilk 
normality test and significant differences in the distribution of EC50 values between species were determined 
using a Mann-Whitney U-test in R.
Prothioconazole sensitivity in planta. Seeds of B. napus, cv. Catana (Dekalb, Monsanto, UK), were 
pre-germinated in a shallow rectangular germination tray (50 × 30 × 8 cm) containing a mixture of 50% enriched 
general-purpose compost (Miracle-Gro, UK) and 50% John Innes No 3 compost (JA Bower, UK). After 10 days 
growth, plants were arranged in an alternate block design (two replicate blocks each containing six treatments 
with eight plants per treatment) located in a plant growth chamber (Conviron Europe, UK). The chamber was set 
to a 12-hour light/12-hour dark cycle with a light intensity of 210 μEm2 s−1. Under regular growing conditions, 
relative humidity in the chamber was set at 70% and temperature was set at 20 °C when light and 18 °C when dark.
After 12 days growth, the cotyledons were inoculated with the conidial suspension of one L. maculans (HROX 
12-2-1) or one L. biglobosa (F2 Exc dm 11-5) isolate by pin-hole wounding50. Conidial suspension (10 µl), at a 
concentration of 106 conidia ml−1, was applied directly to each wound site. After inoculation, the plants were left 
for 24 hours in darkness and 100% humidity, before re-establishing normal growing conditions. At 6 days post 
inoculation (DPI), commercial grade prothioconazole was applied at a concentration of 2 µg ml−1 or 20 µg ml−1 
using a water atomiser. Untreated control (0 µg ml−1 prothioconazole) cotyledons were sprayed with water.
Disease assessments were completed by measuring lesion diameter (mm) at 14 DPI. The cotyledons were 
subsequently removed, instantly frozen in liquid nitrogen and stored at −80 °C for qPCR analysis. Frozen leaves 
were ground into a fine powder and DNA was extracted and diluted to a concentration of 25 ng μl−1 (starting con-
centration). Amplification of L. maculans or L. biglobosa DNA was done using LmacF/LmacR or LbigF/LmacR 
primers, respectively. The PCR reactions used Brilliant III Ultra-fast SYBR Green qPCR master mix with low Rox 
at a final volume of 20 μl and a primer concentration of 0.3 μM. PCR parameters were as follows: initial denatur-
ation at 95 °C for 2 min, followed by 40 cycles of 95 °C for 15 sec, 60 °C (L. maculans) or 55 °C (L. biglobosa) for 
30 sec and 72 °C for 36 sec.
Distribution of data was determined using a Shapiro-Wilk normality test in R. Significant differences in 
lesion sizes between species and between fungicide concentrations were determined independently using a 
Kruskal-Wallis rank sum test in R. Significant differences in DNA quantity between species were determined 
using One-Way ANOVA and post hoc Tukey honest significant test in R.
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